Unit Outline
CSA414
Clinical Pharmacokinetics 4
Health Study Period 1, 2025
Daniel Hoyle
School of Pharmacy and Pharmacology
College of Health and Medicine
CRICOS Provider Code: 00586B

Unit Coordinator
Daniel Hoyle
Email: Daniel.Hoyle@utas.edu.au
 

What is the Unit About?
Unit Description
In Clinical Pharmacokinetics 4, you will deepen your understanding of how pharmacokinetic principles are applied in clinical practice, building on the foundations laid in previous units. This unit will focus on the mechanisms of drug absorption, distribution, metabolism, and excretion (ADME), with particular emphasis on how these processes vary between individuals due to factors such as genetics, age, disease states, and drug interactions. You will explore these sources of interpatient variability through clinically oriented problems and case studies, reinforcing your ability to apply this knowledge in real-world scenarios. Therapeutic drug monitoring will be a key focus, enabling you to actively contribute to improved drug use and patient outcomes. By the end of this unit, you will be equipped to apply pharmacokinetic principles to optimise pharmacotherapy across diverse patient populations.
Intended Learning Outcomes
As per the Assessment and Results Policy 1.3, your results will reflect your achievement against specified learning outcomes.
On completion of this unit, you will be able to:
1
Optimise medication use by using pharmacokinetic principles.
2
Perform advanced pharmaceutical and pharmacokinetic calculations used in pharmacy and clinical practice.
3
Deliver pharmacokinetic-related health and medicines advice and/or education to diverse audiences.
Requisites
REQUISITE TYPE
REQUISITES
Pre-requisite
CSA306 and CSA357 and CSA321
Alterations as a result of student feedback
Based on student feedback, several alterations have been made to CSA414. First, in-class tests have been removed and remaining assessments re-weighted. Second, the video portfolio requirements have been reduced from three to two videos. Third, the final examination will be held within the study period and its duration reduced to one hour. 
As always, the teaching team will greatly appreciate your feedback both informally during the delivery of the unit in 2025, and formally through the University of Tasmania’s Unit Survey following your completion of the unit. 
 
 

Teaching arrangements
ATTENDANCE MODE
TEACHING TYPE
LEARNING ACTIVITY
CONTACT HOURS
FREQUENCY
On Campus
Workshop
2hr workshop weekly
2
Weekly
Independent Learning
Self-directed study
4
Weekly
Other
50 minute mid study period on campus test
1
Once only
Other
Final written test - on campus
1
Once only
Attendance / engagement expectations
If your unit is offered On campus, it is expected that you will attend all on-campus and onsite learning activities. This is to support your own learning and the development of a learning community within the unit. If you are unable to attend regularly, please discuss the situation with your course coordinator and/or our UConnect support team.

If your unit is offered Online or includes online activities, it is expected you will engage in all those activities as indicated in the Unit Outline or MyLO, including any self-directed learning.

If you miss a learning activity for a legitimate reason (e.g., illness, carer responsibilities) teaching staff will attempt to provide alternative activities (e.g., make up readings) where it is possible.
 
As always, the teaching team will greatly appreciate your feedback both informally during the delivery of the unit in 2025, and formally through the University of Tasmania’s Unit Survey following your completion of the unit. 
It is expected that you will attend all on-campus and onsite learning activities. This is to support your own learning and the development of a learning community within the unit. If you are unable to attend regularly, please discuss the situation with your course coordinator and/or our UConnect support team. 
 
Please note, you must be present on campus to undertake Assessment Task 2 and 3. 
 
 

How will I be Assessed?
 
For more detailed assessment information please see MyLO.
Assessment schedule
ASSESSMENT TASK #
ASSESSMENT TASK NAME
DATE DUE
WEIGHT
LINKS TO INTENDED LEARNING OUTCOMES
Assessment Task 1:
Portfolio
Week 5
30 %
LO1, LO3
Assessment Task 2:
Mid-Health Study Period Written test
Week 8
30 %
LO1, LO2, LO3
Assessment Task 3:
Final Case-based Written Test
Week 12
40 %
LO1, LO2, LO3
 
Assessment details
Assessment Task 1: Portfolio
Task Description:
You will be required to build an individual portfolio of short videos that demonstrates the communication of pharmacokinetic principles to a variety of audiences utilising audiovisual media.
Task Length:
Variable
Due Date:
Week 5
Weight:
30 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Communicate pharmacokinetic principles with depth, clarity and language tailored to the target audience and media type.
LO3
2
Analyse clinical problems or improve medication use by applying pharmacokinetic principles.
LO1
 
Assessment Task 2: Mid-Health Study Period Written test
Task Description:
You will undertake a case-based written mid-study period test, which will include multi-choice questions and short-answer questions.
Task Length:
45 minutes + 5 minutes reading time
Due Date:
Week 8
Weight:
30 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
 

1
Analyse clinical problems and improve medication use by applying pharmacokinetic principles.
LO1
2
Perform pharmaceutical and pharmacokinetic calculations used in pharmacy and clinical practice.
LO2
3
Communicate pharmacokinetic principles to a range of audiences.
LO3
 
Assessment Task 3: Final Case-based Written Test
Task Description:
You will undertake a case-based written test, which will include multi-choice questions and short-answer questions.
Task Length:
60 minutes + 10 minutes reading time
Due Date:
Week 12
Weight:
40 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Deconstruct clinical problems and improve medication use by applying pharmacokinetic principles.
LO1
2
Perform advanced pharmaceutical and pharmacokinetic calculations used in pharmacy and clinical practice
LO2
3
Communicate pharmacokinetic principles with depth, clarity and language tailored to the target audience.
LO3
 
 
 

How your final result is determined
To pass this unit, you need to demonstrate your attainment of each of the Intended Learning Outcomes and achieve a final unit grade of 50% or greater.
Academic progress review
The results for this unit may be included in a review of your academic progress. For information about progress reviews and what they mean for all students, see Academic Progress Review in the Student Portal.
Submission of assignments
Where practicable, assignments should be submitted to an assignment submission folder in MYLO. You must submit assignments by the due date or receive a penalty (unless an extension of time has been approved by the Unit Coordinator). Students submitting any assignment in hard copy, or because of a practicum finalisation, must attach a student cover sheet and signed declaration for the submission to be accepted for marking.
Academic integrity
Academic integrity is about acting responsibly, honestly, ethically, and collegially when using, producing, and communicating information with other students and staff members.

In written work, you must correctly reference the work of others to maintain academic integrity. To find out the referencing style for this unit, see the assessment information in the MyLO site, or contact your teaching staff. For more detail about Academic Integrity, see
Important Guidelines & Support.
Requests for extensions
If you are unable to submit an assessment task by the due date, you should apply for an extension.
 
A request for an extension should first be discussed with your Unit Coordinator or teaching support team where possible. A request for an extension must be submitted by the assessment due date, except where you can provide evidence it was not possible to do so. Typically, an application for an extension will be supported by documentary evidence: however, where it is not possible for you to provide evidence please contact your Unit Coordinator.
 
The Unit Coordinator must notify you of the outcome of an extension request within 3 working days of receiving the request.
Late penalties
Assignments submitted after the deadline will receive a late penalty of 5% of the original available mark for each calendar day (or part day) that the assignment is late. Late submissions will not be accepted more than 10 calendar days after the due date, or after assignments have been returned to other students on a scheduled date, whichever occurs first. Further information on Late Penalties can be found on the Assessments and Results Procedure.
 

Review of results and appeals
You are entitled to ask for a review of the marking and grading of your assessment task if there is an irregularity in the marking standards or an error in the process for determining the outcome of an assessment. Details on how to request a review of a mark for an assignment are outlined in the Review and Appeal of Academic Decisions Procedure.
 
 
 

Required Resources
Required reading materials
No required reading materials.
 
Recommended reading materials
Birkett DJ. Pharmacokinetics Made Easy, McGraw Hill: 2009.
Shargel L, Wu-Pong S, Yu ABC: Applied Biopharmaceutics and Pharmacokinetics, 7th Edition, McGraw Hill: 2016. (accessible for free via Access Pharmacy online)
Recommended Readings will be provided by your Unit Coordinator via the Reading List link in MyLO, or the unit Reading List on the University Library website. 
 
Other required resources